← Back to Clinical Trials
Recruiting NCT07186673

NCT07186673 Hall Technique vs Conventional Crown Restoration in Permanent Molars: Split-Mouth Trial in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07186673
Status Recruiting
Phase
Sponsor Latakia University
Condition Permanent Molars
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2025-12-01
Primary Completion 2026-08-01

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 15 Years
Study Type INTERVENTIONAL
Interventions
Stainless steel crown placement using Hall TechniqueStainless steel crown placement using conventional method

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10 participants in total. It began in 2025-12-01 with a primary completion date of 2026-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to compare the clinical and radiographic success of stainless steel crowns placed using the Hall Technique versus the conventional method in the restoration of permanent first molars in children, and to evaluate their effects on occlusal relationships, crown adaptation, and patient satisfaction. Study Outcomes The primary outcome of this study was to evaluate the clinical and radiographic success of stainless steel crowns placed on permanent first molars using the Hall Technique in comparison to the conventional crown placement method. The secondary outcomes included assessment of the marginal fit and adaptation of preformed crowns using both techniques, analysis of changes in occlusal relationships-specifically the vertical dimension of occlusion and overbite-and evaluation of patient satisfaction. Patient satisfaction was measured using a five-point Likert scale at multiple time points: immediately post-treatment, and at one, three, and six months.

Eligibility Criteria

Inclusion Criteria (Clinical): * No signs or symptoms of irreversible pulpitis * Molars with carious lesions affecting two or more surfaces * Permanent first molars with developmental defects Inclusion Criteria (Radiographic): * First molars with an intact dentin layer visible radiographically * No signs of internal or external resorption * No evidence of periradicular bone resorption Exclusion Criteria: * Patients with known nickel allergy * Severely damaged molars not restorable with preformed crowns * First molars without opposing teeth * Pulp exposure during caries excavation

Contact & Investigator

Central Contact

Nabih Raslan, Prof

✉ raslan.nabih@tishreen.edu.sy

📞 +963999140762

Principal Investigator

Nabih Raslan

STUDY CHAIR

Latakia University

Frequently Asked Questions

Who can join the NCT07186673 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 15 Years, studying Permanent Molars. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07186673 currently recruiting?

Yes, NCT07186673 is actively recruiting participants. Contact the research team at raslan.nabih@tishreen.edu.sy for enrollment information.

Where is the NCT07186673 trial being conducted?

This trial is being conducted at Latakia, Syria, Latakia, Syria, Latakia, Syria.

Who is sponsoring the NCT07186673 clinical trial?

NCT07186673 is sponsored by Latakia University. The principal investigator is Nabih Raslan at Latakia University. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology